Successful Management of Graft Reinfection of HCV Genotype 2 in Living Donor Liver Transplantation from a Hepatitis B Core Antibody-Positive Donor with Sofosbuvir and Ribavirin

Direct-acting antivirals (DAAs) are relatively safe and highly effective for the eradication of hepatitis C virus (HCV) in liver transplant recipients. In this case study, we present a female with a graft reinfected with HCV genotype 2 who was treated with a combination of sofosbuvir and ribavirin a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasaki, Reina, Kanda, Tatsuo, Ohtsuka, Masayuki, Yasui, Shin, Haga, Yuki, Nakamura, Masato, Yokoyama, Masayuki, Wu, Shuang, Nakamoto, Shingo, Arai, Makoto, Maruyama, Hitoshi, Miyazaki, Masaru, Yokosuka, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2016
Materias:
Single Case
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5043295/
https://www.ncbi.nlm.nih.gov/pubmed/27721720
http://dx.doi.org/10.1159/000447423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5043295/
https://www.ncbi.nlm.nih.gov/pubmed/27721720
http://dx.doi.org/10.1159/000447423

Ejemplares similares